Image credit: Shutterstock.com
Organon India will be launched in India as a wholly-owned subsidiary of Organon & Co, a global healthcare company focussed on meeting the healthcare needs of women. The company will focus its efforts on building a healthier every day for every woman. In India, Organon will be operating in women’s healthcare, fertility, dermatology, respiratory and bone health products in their portfolio. Organon India will be operating with its in-house sales force and alliance partners across the various markets.
“As a business strategy, we will listen to women to understand their healthcare needs and find solutions which are relevant to them. We will consistently make efforts to ensure availability and access to quality healthcare products for women,” said Anjan Sen, who will lead the operations for India and countries in the South Asia region.
The Organon Executive Leadership Team will ring the opening bell at the New York Stock Exchange (NYSE) today to mark the first day of active trading. Recognising the need to listen to and act on women’s experiences to address the challenges in women’s health, Organon gathered voices from around the world to create the 'Wall of Voices', a multimedia installation outside of the NYSE sharing powerful perspectives, voices, and images.
